Skip to main content
logo
Aptevo Therapeutics Inc. (APVO)
NASDAQ: APVO · Real-Time Price · USD
1.345
-0.015 (-1.10%)
Nov 4, 2026, 12:02 PM EST - Market open

Aptevo Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-26.41-25.97-24.13-17.418.03-28.46
Depreciation & Amortization
0.20.240.350.570.91.14
Loss (Gain) From Sale of Assets
----0.050
Stock-Based Compensation
0.190.11.072.191.81.64
Other Operating Activities
1.081.091.10.01-33.946.64
Change in Accounts Receivable
---2.51.16-1.3
Change in Accounts Payable
0.79-0.16-1.020.52-0.39-1.92
Change in Other Net Operating Assets
-1.2-0.89-1.16-0.111.370.56
Operating Cash Flow
-25.34-25.59-23.79-11.73-21.02-21.68
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-----0.03-0.71
Investing Cash Flow
-----0.03-0.71

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
----3.47-12.27-10.55
Net Debt Issued (Repaid)
----3.47-12.27-10.55
Issuance of Common Stock
25.7338.515.139.486.9311.44
Repurchase of Common Stock
---0-0.01-0-
Other Financing Activities
-0-0.47-2.7225.27
Financing Cash Flow
25.7338.515.66-2.6226.16

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
0.3912.91-8.19-5.73-23.673.77

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-25.34-25.59-23.79-11.73-21.05-22.39
Free Cash Flow Growth
------
Free Cash Flow Margin
-----676.01%-182.17%
Free Cash Flow Per Share
-28.41-81.11----
Levered Free Cash Flow
-15.56-15.88-15.52-11.7-29.322.01
Unlevered Free Cash Flow
-15.56-15.88-15.52-11.7-29.322.01

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
-0.41-1.05-2.182.912.14-2.66
SEC Filings: 10-K · 10-Q